Accès gratuit
Numéro
Med Sci (Paris)
Volume 21, Numéro 5, Mai 2005
Page(s) 507 - 511
Section M/S revues
DOI https://doi.org/10.1051/medsci/2005215507
Publié en ligne 15 mai 2005
  1. Issemann, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990; 347 : 645–50.
  2. Debril MB, Renaud JP, Fajas L, Auwerx J. The pleiotropic functions of peroxisome proliferator-activated receptor gamma. J Mol Med 2001; 79 : 30–47.
  3. Komar CM, Braissant O, Wahli W, Curry TE Jr. Expression and localization of PPARs in the rat ovary during follicular development and the periovulatory period. Endocrinology 2001; 142 : 4831–8.
  4. Froment P, Fabre S, Dupont J, et al. Expression and functional role of peroxisome proliferator-activated receptor-gamma in ovarian folliculogenesis in the sheep. Biol Reprod 2003; 69 : 1665–74.
  5. Mouihate A, Boisse L, Pittman QJ. A novel antipyretic action of 15-deoxy-Delta12,14-prostaglandin J2 in the rat brain. J Neurosci 2004; 24 : 1312–8.
  6. Heaney AP, Fernando M, Melmed S. PPAR-gamma receptor ligands : novel therapy for pituitary adenomas. J Clin Invest 2003; 111 : 1381–8.
  7. Gasic S, Bodenburg Y, Nagamani M, et al. Troglitazone inhibits progesterone production in porcine granulosa cells. Endocrinology 1998; 139 : 4962–6.
  8. Lohrke B, Viergutz T, Shahi SK, et al. Detection and functional characterisation of the transcription factor peroxisome proliferator-activated receptor gamma in lutein cells. J Endocrinol 1998; 159 : 429–39.
  9. Schoppee PD, Garmey JC, Veldhuis JD. Putative activation of the peroxisome proliferator-activated receptor gamma impairs androgen and enhances progesterone biosynthesis in primary cultures of porcine theca cells. Biol Reprod 2002; 66 : 190–8.
  10. Mu YM, Yanase T, Nishi Y, et al. Insulin sensitizer, troglitazone, directly inhibits aromatase activity in human ovarian granulosa cells. Biochem Biophys Res Commun 2000; 271 : 710–3.
  11. Viergutz T, Loehrke B, Poehland R, et al. Relationship between different stages of the corpus luteum and the expression of the peroxisome proliferator-activated receptor gamma protein in bovine large lutein cells. J Reprod Fertil 2000; 118 : 153–61.
  12. Cui Y, Miyoshi K, Claudio E, et al. Loss of the peroxisome proliferation-activated receptor gamma (PPARgamma) does not affect mammary development and propensity for tumor formation but leads to reduced fertility. J Biol Chem 2002; 277 : 17830–5.
  13. Dunaif A. Insulin resistance and the polycystic ovary syndrome : mechanism and implications for pathogenesis. Endocrinol Rev 1997; 18 : 774–800.
  14. Dunaif A, Scott D, Finegood D, et al. The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Clin Endocrinol Metab 1996; 81 : 3299–306.
  15. Iuorno MJ, Nestler JE. Insulin-lowering drugs in polycystic ovary syndrome. Obstet Gynecol Clin North Am 2001; 28 : 153–64.
  16. Seli E, Duleba AJ. Treatment of PCOS with metformin and other insulin-sensitizing agents. Curr Diab Rep 2004; 4 : 69–75.
  17. La Marca A, Egbe TO, Morgante G, et al. Metformin treatment reduces ovarian cytochrome P-450c17alpha response to human chorionic gonadotrophin in women with insulin resistance-related polycystic ovary syndrome. Hum Reprod 2000; 15 : 21–3.
  18. Nestler JE, Jakubowicz DJ, Reamer P, et al. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. N Engl J Med 1999; 340 : 1314–20.
  19. Duran-Sandoval D, Thomas AC, Bailleul B, et al. Pharmacology of PPARalpha, PPARgamma and dual PPARalpha/gamma agonists in clinical development. Med Sci (Paris) 2003; 19 : 819–25.
  20. Larsen TM, Toubro S, Astrup A. PPARgamma agonists in the treatment of type II diabetes : is increased fatness commensurate with long-term efficacy ? Int J Obes Relat Metab Disord 2003; 27 : 147–61.
  21. Bjorntorp P. The regulation of adipose tissue distribution in humans. Int J Obes Relat Metab Disord 1996; 20 : 291–302.
  22. Brettenthaler N, De Geyter C, Huber PR, Keller U. Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2004; 89 : 3835–40.
  23. Gurnell M, Savage DB, Chatterjee VK, O’Rahilly S. The metabolic syndrome : peroxisome proliferator-activated receptor gamma and its therapeutic modulation. J Clin Endocrinol Metab 2003; 88 : 2412–21.
  24. Altshuler D, Hirschhorn JN, Klannemark M, et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000; 26 : 76–80.
  25. Hara M, Alcoser SY, Qaadir A, et al. Insulin resistance is attenuated in women with polycystic ovary syndrome with the Pro(12)Ala polymorphism in the PPARgamma gene. J Clin Endocrinol Metab 2002; 87 : 772–5.
  26. Barak Y, Nelson MC, Ong ES, et al. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 1999; 4 : 585–95.
  27. Mohan M, Ryder S, Claypool PL, et al. Analysis of gene expression in the bovine blastocyst produced in vitro using suppression-subtractive hybridization. Biol Reprod 2002; 67 : 447–53.
  28. Kubota N, Terauchi Y, Miki H, et al. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 1999; 4 : 597–609.
  29. Wendling O, Chambon P, Mark M. Retinoid X receptors are essential for early mouse development and placentogenesis. Proc Natl Acad Sci USA 1999; 96 : 547–51.
  30. Li Q, Cheon YP, Kannan A, et al. A novel pathway involving progesterone receptor, 12/15-lipoxygenase-derived eicosanoids, and peroxisome proliferator-activated receptor gamma regulates implantation in mice. J Biol Chem 2004; 279 : 11570–81.
  31. Asami-Miyagishi R, Iseki S, Usui M, et al. Expression and function of PPARgamma in rat placental development. Biochem Biophys Res Commun 2004; 315 : 497–501.
  32. Tarrade A, Schoonjans K, Guibourdenche J, et al. PPAR gamma/RXR alpha heterodimers are involved in human CG beta synthesis and human trophoblast differentiation. Endocrinology 2001; 142 : 4504–14.
  33. Nogueiras R, Barreiro ML, Caminos JE, et al. Novel expression of resistin in rat testis : functional role and regulation by nutritional status and hormonal factors. J Cell Sci 2004; 117 : 3247–57.
  34. Pritts EA, Zhao D, Ricke E, et al. PPAR-gamma decreases endometrial stromal cell transcription and translation of RANTES in vitro. J Clin Endocrinol Metab 2002; 87 : 1841–4.
  35. Wanichkul T, Han S, Huang RP, Sidell N. Cytokine regulation by peroxisome proliferator-activated receptor gamma in human endometrial cells. Fertil Steril 2003; 79 (suppl 1) : 763–9.
  36. Dufour JM, Vo MN, Bhattacharya N, et al. Peroxisome proliferators disrupt retinoic acid receptor alpha signaling in the testis. Biol Reprod 2003; 68 : 1215–24.
  37. Kobayashi T, Niimi S, Kawanishi T, et al. Changes in peroxisome proliferator-activated receptor gamma-regulated gene expression and inhibin/activin-follistatin system gene expression in rat testis after an administration of di-n-butyl phthalate. Toxicol Lett 2003; 138 : 215–25.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.